Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
Colorectal cancer (CRC) is still the third most common cancer and the second most common causes of cancer-related death around the world. Metformin, a biguanide, which is widely used for treating diabetes mellitus, has recently been shown to have a suppressive effect on CRC risk and mortality, but n...
Main Authors: | Xinbing Sui, Yinghua Xu, Jie Yang, Yong Fang, Haizhou Lou, Weidong Han, Maolin Zhang, Wei Chen, Kaifeng Wang, Da Li, Wei Jin, Fang Lou, Yu Zheng, Hong Hu, Liu Gong, Xiaoyun Zhou, Qin Pan, Hongming Pan, Xian Wang, Chao He |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4029793?pdf=render |
Similar Items
-
AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review
by: Dora Višnjić, et al.
Published: (2021-05-01) -
The effect of an intracerebroventricular injection of metformin or AICAR on the plasma concentrations of melatonin in the ewe: potential involvement of AMPK?
by: Collet Armelle, et al.
Published: (2011-07-01) -
The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts.
by: Kuan-Hsing Chen, et al.
Published: (2014-01-01) -
AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.
by: Shudong Liu, et al.
Published: (2015-01-01) -
The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
by: Derek T Hall, et al.
Published: (2018-07-01)